Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Pharmaceutics|April 3, 2019
Smart Nanovesicles for Drug Targeting and DeliveryCarlotta Marianecci, Maria Carafa
Drug Delivery and Translational Research|November 30, 2022
Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributesDiego Alejandro Dri, Federica Rinaldi, Maria Carafa, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 30, 2004
Non-phospholipid vesicles for pulmonary glucocorticoid deliveryClaudio Terzano, Luigi Allegra, Franco Alhaique, et al.
Colloids and Surfaces. B, Biointerfaces|September 14, 2010
Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20Luisa Di Marzio, Carlotta Marianecci, Mariadea Petrone, et al.
Current Drug Targets|March 28, 2013
Niosomes encapsulating Ibuprofen-cyclodextrin complexes: preparation and characterizationCarlotta Marianecci, Federica Rinaldi, Sara Esposito, et al.
Colloids and Surfaces. B, Biointerfaces|January 15, 2013
Polysorbate 20 vesicles as oral delivery system: in vitro characterizationLuisa Di Marzio, Sara Esposito, Federica Rinaldi, et al.
Pharmaceutics|April 3, 2021
Surfactants, Nanomedicines and Nanocarriers: A Critical Evaluation on Clinical TrialsDiego Alejandro Dri, Carlotta Marianecci, Maria Carafa, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 7, 2010
Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblastsCarlotta Marianecci, Donatella Paolino, Christian Celia, et al.
Journal of Liposome Research|October 30, 2009
Span and Tween neutral and pH-sensitive vesicles: characterization and in vitro skin permeationMaria Carafa, Carlotta Marianecci, Federica Rinaldi, et al.
Journal of Drug Targeting|November 9, 2006
Maleic- and fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulationAntonio Di Stefano, Piera Sozio, Antonio Iannitelli, et al.
Pageof 9